Nurix Therapeutics, Inc. ($NRIX)
Hansen Gwenn โ Chief Scientific Officer
Shares
1,452
Price
$0.00
Total Value
$0.00
Nearby Earnings
Oct 8, 2026
EPS:Est: -0.60
Revenue:Est: $24.35M
Transaction Details
| Insider | Hansen Gwenn |
|---|---|
| Title | Chief Scientific Officer |
| Transaction Date | Oct 15, 2026 |
| Expiration Date | Aug 28, 2029 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Disposed |
| Security | Employee Stock Option (right to buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Oct 15, 2026 |
| Shares Purchased | 1,452 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 59,406 |
| Derivative | Derivative |
| Accession Number | 0001817160-26-000021 |
| Document | View SEC Filing |